New drug hopes to tackle MASH cirrhosis
NCT ID NCT07325526
First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 6 times
Summary
This study tests a new medicine called BI 3802876 in adults with compensated cirrhosis caused by MASH (a type of fatty liver disease). The main goal is to see if the drug is safe and how the body handles it. Participants receive either the drug or a placebo as an infusion, and are followed for about six months with 12 clinic visits.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- BI 3802876 (a drug given as an infusion into a vein)
- What this could lead to
- If successful, this could point toward a treatment to improve liver health in people with MASH-related cirrhosis.
- What could go wrong
- This is an early Phase 2 trial with only 29 participants, so results may not apply to everyone. The drug may cause side effects or fail to show benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COMPENSATED CIRRHOSIS DUE TO METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
American Research Corporation at the Texas Liver Institute
RECRUITINGSan Antonio, Texas, 78215, United States
-
Arizona Clinical Trials - Chandler
NOT_YET_RECRUITINGChandler, Arizona, 85225, United States
-
Baylor Scott & White Research Institute
NOT_YET_RECRUITINGDallas, Texas, 75246, United States
-
Catalina Research Institute, LLC
RECRUITINGMontclair, California, 91763, United States
-
Centricity Research Columbus Georgia Multispecialty
RECRUITINGColumbus, Georgia, 31904, United States
-
Columbia University Medical Center
NOT_YET_RECRUITINGNew York, New York, 10032, United States
-
Covenant Metabolic Specialists, LLC - University Park
RECRUITINGUniversity Park, Florida, 34201, United States
-
Epic Medical Research - Carrollton
RECRUITINGCarrollton, Texas, 75006, United States
-
Epic Medical Research - Fort Worth
RECRUITINGFort Worth, Texas, 76120, United States
-
Houston Methodist Hospital
NOT_YET_RECRUITINGHouston, Texas, 77030, United States
-
Johns Hopkins Hospital
NOT_YET_RECRUITINGBaltimore, Maryland, 21287, United States
-
Kaiser Permanente - Los Angeles Medical Center
NOT_YET_RECRUITINGLos Angeles, California, 90027, United States
-
Lucas Research, Inc.
RECRUITINGMorehead City, North Carolina, 28557, United States
-
Mayo Clinic, Rochester
NOT_YET_RECRUITINGRochester, Minnesota, 55905, United States
-
Medical University of South Carolina
RECRUITINGCharleston, South Carolina, 29425, United States
-
Nashville General Hospital
RECRUITINGNashville, Tennessee, 37209, United States
-
Panax Clinical Research
RECRUITINGMiami Lakes, Florida, 33014, United States
-
Peak Gastroenterology Associates
RECRUITINGColorado Springs, Colorado, 80907, United States
-
Pioneer Research Solutions, Inc.
RECRUITINGHouston, Texas, 77099, United States
-
Schiff Center Liver Diseases
NOT_YET_RECRUITINGMiami, Florida, 33136, United States
-
Southern California Research Center
RECRUITINGCoronado, California, 92118, United States
-
Texas Clinical Research Institute, LLC
NOT_YET_RECRUITINGArlington, Texas, 76012, United States
-
The Liver Institute at Methodist Dallas
NOT_YET_RECRUITINGDallas, Texas, 75203, United States
-
University of Alberta Hospital (University of Alberta)
NOT_YET_RECRUITINGEdmonton, Alberta, T6G 2XB, Canada
-
University of Iowa Hospitals and Clinics
NOT_YET_RECRUITINGIowa City, Iowa, 52242, United States
-
University of Kansas Medical Center
NOT_YET_RECRUITINGKansas City, Kansas, 66160, United States
-
Velocity Clinical Research, San Diego
NOT_YET_RECRUITINGLa Mesa, California, 91942, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple scan and blood test outsmart liver cancer?
- A new procedure may offer relief for Cirrhosis-Related fluid buildup
- Can liver damage predict how drugs behave?
- Better crystal ball for liver crisis: new scores put to the test
- Blood thinner may stop early cirrhosis from turning deadly — a major trial puts it to the test
- Stick-On ultrasound patch could spot liver damage without a specialist